Abstract: The present invention relates to a composition for diagnosing bone metastasis of cancer, a method for providing information needed for diagnosis of bone metastasis of cancer using same, a method for providing information needed for monitoring responses to treatment of bone metastasis of cancer using same, and a method for screening a therapeutic agent for bone metastasis of cancer using same. The composition for diagnosing bone metastasis of cancer of the present invention has the effect of effectively diagnosing bone metastasis of cancer at an early stage.

Abstract: The present invention relates to a method of preparing ultra-pure silicon carbide in which a super-porous spherical silica aerogel is used as a silica raw material. By preparing the silica aerogel particles using low-cost water glass, a reaction area with respect to a carbon raw material is increased to enable low-temperature synthesis of silicon carbide, the size and shape of silicon carbide powder may be uniformly controlled to prepare ultra-pure silicon carbide, and economic efficiency and productivity of the silicon carbide synthesis may be improved. Thus, it is expected that the silicon carbide powder prepared by the preparation method of the present invention may be provided as an optimized raw material for the preparation of silicon carbide sintered body and single crystal (ingot).

Abstract: Disclosed are a method and apparatus for estimating lithofacies by learning well logs. The method includes a model formation step of forming lithofacies estimation model to output lithofacies corresponding to measured depth when the well logs are input based on train data sets including train data having values of multiple factors included in the well logs, the values being arranged corresponding to measured depth, and label data having lithofacies corresponding to measured depth as answers, and lithofacies estimation step of inputting unseen data having values of multiple factors included in well logs acquired from a well at which lithofacies are to be estimated, the values being arranged corresponding to measured depth, to the lithofacies estimation model to estimate lithofacies corresponding to measured depth.

Abstract: Disclosed are a method and apparatus for estimating S-wave velocities by learning well logs, whereby the method includes a model formation step of forming an S-wave estimation model to output S-wave velocities corresponding to measured depth when the well logs are input based on train data sets including train data having values of multiple factors included in the well logs, the values being arranged corresponding to measured depth, and label data having S-wave velocities corresponding to measured depth as answers, and an S-wave velocity estimation step of inputting unseen data having values of multiple factors included in well logs acquired from a well at which S-wave velocities are to be estimated, the values being arranged corresponding to measured depth, to the S-wave estimation model to estimate S-wave velocities corresponding to measured depth.

Abstract: The invention relates to a soft starter (10) for connecting at least one main circuit (12, 14, 16), each of which includes a bypass circuit (20) having a semiconductor switch (22). Said soft starter (10) comprises a control unit (40) for actuating the bypass circuit (20), and the control unit (40) is equipped with a control signal input (44). According to the invention, the control unit (40) has a separate safety signal input (42).

Abstract: The present disclosure provides an aerogel-containing composition including an aerogel, a water-soluble binder, a foaming agent, and a mixture of water and a polar organic solvent as a solvent, and an insulation blanket prepared using the same. In the aerogel-containing composition, the aerogel is uniformly dispersed in the composition, and when preparing a blanket, an insulation blanket having low thermal conductivity and flexibility of low density is prepared without concern of shrinkage of the substrate for a blanket and detachment of the aerogel during a drying process.

Abstract: The present disclosure provides an aerogel-containing composition including an aerogel, a water-soluble binder, a foaming agent, and a mixture of water and a polar organic solvent as a solvent, and an insulation blanket prepared using the same. In the aerogel-containing composition, the aerogel is uniformly dispersed in the composition, and when preparing a blanket, an insulation blanket having low thermal conductivity and flexibility of low density is prepared without concern of shrinkage of the substrate for a blanket and detachment of the aerogel during a drying process.

Abstract: The present disclosure provides an aerogel-containing composition including an aerogel, a water-soluble binder, a foaming agent, and a mixture of water and a polar organic solvent as a solvent, and an insulation blanket prepared using the same. In the aerogel-containing composition, the aerogel is uniformly dispersed in the composition, and when preparing a blanket, an insulation blanket having low thermal conductivity and flexibility of low density is prepared without concern of shrinkage of the substrate for a blanket and detachment of the aerogel during a drying process.

Abstract: Provided is a peptide for targeting gastric cancer, a composition for diagnosing radioresponsiveness-dependent gastric cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.

Abstract: Provided is a peptide for targeting colorectal cancer, a composition for diagnosing radioresponsiveness-dependent prognosis of colorectal cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, in consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.

Abstract: The present invention relates to a method of preparing ultra-pure silicon carbide in which a super-porous spherical silica aerogel is used as a silica raw material. By preparing the silica aerogel particles using low-cost water glass, a reaction area with respect to a carbon raw material is increased to enable low-temperature synthesis of silicon carbide, the size and shape of silicon carbide powder may be uniformly controlled to prepare ultra-pure silicon carbide, and economic efficiency and productivity of the silicon carbide synthesis may be improved. Thus, it is expected that the silicon carbide powder prepared by the preparation method of the present invention may be provided as an optimized raw material for the preparation of silicon carbide sintered body and single crystal (ingot).

Abstract: The present invention relates to a method for preparing spherical silica aerogel granules and spherical silica aerogel granules prepared thereby. The method for preparing spherical silica aerogel granules, which is suitable for mass production because droplets of a water glass solution are uniformly dispersed with a uniform size in a non-aqueous solvent using a surfactant in a certain step to reduce a process time and enhance productivity, may be provided. The spherical silica aerogel granules having a uniform size prepared by the method may be provided, wherein the spherical silica aerogel granules have a high working property and excellent flowability.

Abstract: The present invention relates to a biomarker composition for diagnosing radiation-resistant cancer comprising LRP-1 as an active ingredient and a method of diagnosing radiation-resistant cancer using the same, and identifies LRP-1 which a binding partner protein to which specific peptide sequences specifically targeting radiation-resistant colon cancer tissues are actually bound, and based on this, suggests the possibility of radiation therapy resistance factor for cancer.

Abstract: The invention relates to a soft starter (10) for connecting at least one main circuit (12, 14, 16), each of which includes a bypass circuit (20) having a semiconductor switch (22). Said soft starter (10) comprises a control unit (40) for actuating the bypass circuit (20), and the control unit (40) is equipped with a control signal input (44). According to the invention, the control unit (40) has a separate safety signal input (42).

Abstract: Provided is a peptide for targeting gastric cancer, a composition for diagnosing radioresponsiveness-dependent gastric cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.

Abstract: A voltage converter includes a converting circuit and a switching control circuit, where the converting circuit includes an inductor connected to a switching node, a first switching device connected between the switching node and a common voltage and a second switching device connected to the switching node, where the first switching device charges the inductor and discharges the inductor in response to a control signal, and the switching control circuit generates the control signal by performing a PWM and a PFM based on a first sensing signal, a second sensing signal and a feedback signal, and adjusts a charging time of the inductor on a time basis, based on at least the input power supply voltage when the switching control circuit performs the PFM.

Abstract: The present invention relates to a method for preparing spherical silica aerogel granules and spherical silica aerogel granules prepared thereby. The method for preparing spherical silica aerogel granules, which is suitable for mass production because droplets of a water glass solution are uniformly dispersed with a uniform size in a non-aqueous solvent using a surfactant in a certain step to reduce a process time and enhance productivity, may be provided. The spherical silica aerogel granules having a uniform size prepared by the method may be provided, wherein the spherical silica aerogel granules have a high working property and excellent flowability.

Abstract: The present disclosure provides an aerogel-containing composition including an aerogel, a water-soluble binder, a foaming agent, and a mixture of water and a polar organic solvent as a solvent, and an insulation blanket prepared using the same. In the aerogel-containing composition, the aerogel is uniformly dispersed in the composition, and when preparing a blanket, an insulation blanket having low thermal conductivity and flexibility of low density is prepared without concern of shrinkage of the substrate for a blanket and detachment of the aerogel during a drying process.

Abstract: Provided is a peptide for targeting colorectal cancer, a composition for diagnosing radioresponsiveness-dependent prognosis of colorectal cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, in consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.

Abstract: Provided is a peptide for targeting gastric cancer, a composition for diagnosing radioresponsiveness-dependent gastric cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.